Intercell to axe jobs after diarrhoea vax patch failure
Intercell has killed development of its Travellers’ Diarrhoea Vaccine Patch after the product failed in clinical trials which will lead to job cuts and a dramatic reduction of R&D expenses.
Archives for December 14, 2010
Novel drug delivery critical to pharma’s future, says report
Pharma should forget about ‘the next blockbuster drug’ and invest more money creating novel drug delivery systems with emerging developers to enhance product value and efficacy, say researchers.
Celerion acts to meet demand for hospital-based US trials
Celerion is partnering to access a medical centre Phase I unit that will support increased demand for trials conducted at US hospitals.
Appointments at PharmaNet, PPD, BASi and WorldCare Clinical – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PharmaNet, PPD, BASi and WorldCare Clinical.
Reckitt Benckiser buys Paras
Reckitt Benckiser said it will pay INR32.6bn for Indian drugmaker Paras Pharmaceuticals to build its position in the consumer healthcare sector.
Drug sector must modernise to cut dependence on foreign firms, says Russian PM
Russia is “becoming dependant” on foreign drugmakers according to Prime Minister Vladimir Putin, who has called for home-grown manufacturers to make more of the country’s medicines.
Caliper to pay $20m for imaging tech firm CRi
Caliper Life sciences has entered into a definitive merger agreement with Cambridge Research & Instrumentation (CRi) to boost its discovery biomarker and personalised medicine development offering.
Vical hails universal vaccine adjuvant in research review
Vical has published a review of Vaxfectin data showing the adjuvant boosts the immune response of DNA-based vaccines against cancer and a range of pathogens.